Position statement supporting House Bill 631 Given before the Senate Finance Committee There have been several high-profile examples in recent years of drug manufacturers sharply hiking prices for no apparent reason beyond increasing profits. These actions harm Maryland residents –
Position statement supporting House Bill 666 Given before the Senate Finance Committee Skyrocketing costs for prescription drugs are a major factor driving up the costs of health care and insurance for everyone. Providing some basic transparency around those cost increases,
Position statement supporting Senate Bill 415 Given before the Senate Finance Committee There have been several high-profile examples in recent years of drug manufacturers sharply hiking prices for no apparent reason beyond increasing profits. These actions harm Maryland residents –
Position statement supporting Senate Bill 437 Given before the Senate Finance Committee Skyrocketing costs for prescription drugs are a major factor driving up the costs of health care and insurance for everyone. Providing some basic transparency around those cost increases,
